Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Neoplasms, Connective and Soft Tissue"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
 Osteosarcoma
Neuroblastoma
Medulloblastoma
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma Kristen N. Ganjoo
 Sarcoma
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Dr. Neyssa Marina
 Sarcoma
Phase II PKC412 in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Jason Robert Gotlib
 Myeloproliferative Disorders
Mastocytosis, Systemic
Leukemia, Mast-Cell
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Dr. Neyssa Marina
 Sarcoma
Ixabepilone in Treating Young Patients With Refractory Solid Tumors Dr. Neyssa Marina
 Sarcoma
Wilms Tumor
Neuroblastoma
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas Kristen N. Ganjoo
 Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
AEWS07B1: A COG Study for Collecting and Banking Ewing Sarcoma Specimens Dr. Neyssa Marina
 Sarcoma
PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases Sanjiv Sam Gambhir M.D., Ph.D.
 Sarcoma and Soft Tissue Cancers
Bone Cancer
Neoplasm Metastasis
Study of Late-Occurring Complications in Childhood Cancer Survivors Dr. Neyssa Marina
 Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms
A Children’s Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens Dr. Neyssa Marina
 Osteosarcoma

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
(Suspended) 		Dr. Neyssa Marina
 Sarcoma
Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
(No longer recruiting) 		Dr. Neyssa Marina
 Sarcoma
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
(No longer recruiting) 		Dr. Neyssa Marina
 Sarcoma
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
(No longer recruiting) 		Jason Robert Gotlib
 Leukemia
Mastocytosis, Systemic
Hypereosinophilic Syndrome
Mastocytosis
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
(Suspended) 		Amreen Husain
 Leiomyosarcoma
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
(No longer recruiting) 		Dr. Neyssa Marina
 Sarcoma
A Phase 1b/2 Study of AMG 655 in Combination With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
(No longer recruiting) 		Kristen N. Ganjoo
 Sarcoma
Neoplasm Metastasis
R1507 in Patients With Recurrent or Refractory Sarcomas
(No longer recruiting) 		Kristen N. Ganjoo
 Sarcoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: